On 29 July 2020, Meyer Burger Technology AG completed a capital increase comprising a rights offering to its shareholders and a private placement to selected investors, resulting in gross proceeds of approximately CHF 165 million. Meyer Burger intends
Tags :Annette Weber
On 28 July 2020, Basilea Pharmaceutica completed the offering of approximately CHF 97 million 3.25% convertible bonds due 2027 to finance the repurchase of a part of Basilea’s existing convertible bonds due 2022. With the repurchase of part of its
The law firm advised Swiss Re on the update of its USD 10 billion debt issuance programme and the offering of EUR 800 million guaranteed Subordinated Notes, as well as SGD 350 million guaranteed subordinated notes
Homburger advised Molecular Partners in this transaction with a team led by partner Dieter Gericke. Bär & Karrer acted as legal counsel to the banking syndicate. The team included partner Thomas Reutter
Ina Invest completes rights offering and listing of shares on SIX after spin-off from Implenia. NKF advised Credit Suisse as the sole bookrunner in connection with the transaction, which represents the first listing and admission
The worldwide supplier of high performance sensor solutions ams completed a capital increase by way of a rights offering raising gross proceeds of approximately CHF 1.75 billion.
La Foncière completed from 16 to 25 March 2020 an increase by 10% of the number of its units (parts) listed on the SIX Swiss Exchange
Zur Rose Group via its subsidiary Zur Rose Finance successfully completed the placement of senior unsecured bonds due 2025 guaranteed by the Company and convertible into registered shares of the Company.
Bär & Karrer acted as Swiss legal advisor to Novartis in the acquisition of NASDAQ-listed biopharmaceutical company The Medicines Company for USD 9.7 billion
